Molecular Profiling as a Novel Tool to Predict Response to Interferon-α2 in MPNs: The Proof of Concept in Early Myelofibrosis

    loading  Checking for direct PDF access through Ovid

Abstract

High-risk mutations are associated with poor response to interferon-α2. Early treatment with interferon-α2 is recommended in patients who have early myelofibrosis without high-risk mutations.

See also pages 2680-7.

    loading  Loading Related Articles